Myriad Genetics Inc (NASDAQ:MYGN)
| 16.62 Delayed Data As of Sep 22 |  -0.15 / -0.89%Today’s Change | 13.92 Today|||52-Week Range 24.21 | +14.54% Year-to-Date |
Latest MYGN News | Press Releases
| Is Myriad Genetics (MYGN) Too Good to Be True? A Comprehensive Analysis of a Potential Value Trap Sep 22 / GuruFocus News - Paid Partner Content | Myriad Genetics' (MYGN) New Deal to Use MRD Testing Platform Sep 19 / Zacks.com - Paid Partner Content |
| Myriad Genetics (MYGN) Secures Key Milestones in Illumina Tie-Up Sep 20 / Zacks.com - Paid Partner Content | Here's Why You Should Retain Myriad Genetics (MYGN) Stock Now Sep 12 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 16.77 |
| Today’s open | 16.76 |
| Day’s range | 16.43 - 16.76 |
| Volume | 21,708 |
| Average volume (3 months) | 523,208 |
| Market cap | $1.4B |
Data as of 3:59pm ET, 09/22/2023
Growth & Valuation
| Earnings growth (last year) | -298.51% |
| Earnings growth (this year) | -7.78% |
| Earnings growth (next 5 years) | -68.57% |
| Revenue growth (last year) | -1.77% |
| P/E ratio | NM |
| Price/Sales | 1.72 |
| Price/Book | 1.53 |
Competitors
Data as of 4:00pm ET, 09/22/2023
Financials
| Next reporting date | October 31, 2023 |
| EPS forecast (this quarter) | -$0.08 |
| Annual revenue (last year) | $678.4M |
| Annual profit (last year) | -$112.0M |
| Net profit margin | -16.51% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Salt Lake City, Utah |
Forecasts
